← Open Payments lookup

RACHEL SCHULZ: Open Payments

NPI 1205484771 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,300 in 50 payments from 17 companies in 2025. Trend: 2023 $887 · 2024 $920 · 2025 $2,300

Food & beverage: $2,211Education: $90
CompanyPaymentsAmount
Janssen Biotech, Inc.14$628
Incyte Corporation4$415
Daiichi Sankyo Inc.6$266
Syndax Pharmaceuticals, Inc.2$174
PFIZER INC.1$125
Stryker Corporation4$115
ABBVIE INC.3$93
Alexion Pharmaceuticals, Inc.1$90
Celgene Corporation3$87
BeOne Medicines USA, Inc.3$76

Products named: RYBREVANT, NIKTIMVO, Vanflyta, CARVYKTI, REVUFORJ, Monjuvi, FLOWTRIEVER CATHETER, S, SOLIRIS.

Industry payments across CA — which companies pay providers there.